Bukwang Pharmaceutical Co., Ltd. (KRX: 003000)

Bukwang Pharmaceutical Revenue

Bukwang Pharmaceutical had revenue of 36.92B KRW in the quarter ending June 30, 2024, a decrease of -14.98%. This brings the company's revenue in the last twelve months to 116.58B, down -39.21% year-over-year. In the year 2023, Bukwang Pharmaceutical had annual revenue of 125.93B, down -34.04%.

• Revenue (ttm): 116.58B
• Revenue Growth: -39.21%
• P/S Ratio: 2.62
• Revenue / Employee: 210.44M
• Employees: 554
• Market Cap: 304.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	125.93B	-64.98B	-34.04%
Dec 31, 2022	190.91B	8.42B	4.61%
Dec 31, 2021	182.49B	12.83B	7.56%
Dec 31, 2020	169.66B	1.47B	0.87%
Dec 31, 2019	168.19B	-26.03B	-13.40%